Section 103 – Manufacturer reports — Insurer report — Publication by department.

Effective 5/4/2022 31A-48-103. Manufacturer reports — Insurer report — Publication by department. (1) (a) A manufacturer of a drug shall, beginning January 1, 2022, report to the department the information described in Subsection (1)(b) no more than 30 days after the day on which an increase to the wholesale acquisition cost of the drug results […]